| Basics |
|
Erasca, Inc.
|
| IPO Date: |
July 16, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$751.73M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.21 | 3.67%
|
| Avg Daily Range (30 D): |
$0.08 | 3.43%
|
| Avg Daily Range (90 D): |
$0.07 | 3.61%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.87M |
| Avg Daily Volume (30 D): |
1.61M |
| Avg Daily Volume (90 D): |
1.15M |
| Trade Size |
| Avg Trade Size (Sh.): |
137 |
| Avg Trade Size (Sh.) (30 D): |
157 |
| Avg Trade Size (Sh.) (90 D): |
165 |
| Institutional Trades |
| Total Inst.Trades: |
442 |
| Avg Inst. Trade: |
$1.95M |
| Avg Inst. Trade (30 D): |
$.91M |
| Avg Inst. Trade (90 D): |
$.92M |
| Avg Inst. Trade Volume: |
.44M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.75M |
| Avg Closing Trade (30 D): |
$.59M |
| Avg Closing Trade (90 D): |
$.85M |
| Avg Closing Volume: |
576.52K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-.43
|
$-.12
|
$-.11
|
|
Diluted EPS
|
$-.43
|
$-.12
|
$-.11
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -128.27M
|
$ -33.88M
|
$ -30.97M
|
|
Operating Income / Loss
|
$ -146.71M
|
$ -38.13M
|
$ -35.63M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -106.66M
|
$ -4.34M
|
$ 2.74M
|
|
PE Ratio
|
|
|
|
|
|
|